how to get glp 1 if you're not overweight Considering GLP-1 drugs for weight loss? Advice from a doctor who's used them : NPR Do you desire to “come

The cohort was 78.6% female, average age 52.7 years

Retatrutide is an investigational triple agonist acting on GLP-1, GIP, and glucagon receptors, not yet approved by the MHRA or EMA for use in the UK

2 In separate clinical studies of adults with overweight or obesity, about 1 in 4 taking Wegovy oral semaglutide 25 mg (64 weeks), about 1 in 3 taking Wegovy injection 2.4 mg (68 weeks), and about 1 in 2 taking Wegovy injection 7.2 mg (72 weeks) lost 20% of body weight, alongside diet and exercise

Being totally transparent is the best way to ensure your doctor understands your situation and can provide advice for your specific situation

These challenges necessitate stringent regulatory frameworks, public engagement, and alternative technological solutions to balance therapeutic potential with ethical responsibility